Skip to main content
Premium Trial:

Request an Annual Quote

Bastian Joins Sigma-Aldrich, DiNuzzo Named EVP at Strategic Diagnostics, Ray Wu Dies, and More

NEW YORK (GenomeWeb News) - Sigma-Aldrich has hired Helge Bastian to be VP of global marketing in the company’s Research Biotech unit. Bastian formerly was executive VP of life sciences services at SGS, and he held various positions at Qiagen, including VP of global strategic marketing and VP of molecular diagnostics.




Fran DiNuzzo will take on the post of executive VP and CCO at Strategic Diagnostics. DiNuzzo formerly was an executive in the BioAnalytical business unit at Agilent Technologies, serving as VP and GM of Chemical Solutions, the company’s services business, and its Integrated Biology Solutions business.




Jose Ordovas has joined Progenika’s scientific advisory board. Ordovas specializes in the genetics of cardiovascular disease, has participated in the Framingham Heart Study for over twenty years, and sits on committees at the American Heart Association and the National Institutes of Health, the company said.




Gentel Biosciences has hired G. Randall Durnell to be VP of commercial operations. Durnell has worked with Beckman Coulter, Aurora Biosciences, and Pierce Biotechnology.




Med BioGene has appointed Dennis Grimaud to its board of directors. Grimaud is CEO of Theragnostix Reference Laboratories and has 20 years of entrepreneurial and executive experience in biotechnology and molecular diagnostics, including two years as CEO of Genaco Biomedical Products.




Genetic sequencing trailblazer and Cornell University molecular biology professor Ray Wu died last week in Ithaca, NY, at the age of 79.

Wu pioneered early DNA sequencing technologies and has been a researcher at Cornell since 1966. He also has worked at the University of Pennsylvania and Stanford University, and he has served as a senior fellow at the National Science Foundation and as a visiting associate professor at the Massachusetts Institute of Technology. Wu also served as a scientific adviser to the governments of China and Taiwan.




NanoInk has appointed Dean Hart to the role of executive VP of commercial operations.

Hart previously was VP of sales and marketing at Vision Point, an equipment and services company. Hart also has been VP of sales at Takeda Pharmaceuticals, senior VP of sales at Takeda Pharmaceuticals North America, president of Sequest Technologies, and national sales director for the US subsidiary of Eisai, a Japanese pharmaceutical company.




Upstream Biosciences has appointed Winston Hide to its scientific advisory board. Hide founded and serves as director of the South African National Bioinformatics Institute at the University of the Western Cape and he is a visiting professor of bioinformatics at the Harvard University School of Public Health. Hide also founded the African Society for Computational Biology and Bioinformatics, established a World Health Organization African Regional Training Center for Bioinformatics, and was a fellow at Baylor College of Medicine’s Department of Molecular Genetics and at the Smithsonian National Museum of Natural History.




Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in PEOPLE, a weekly roundup of industry comings and goings.
The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.